Synthesis from quebrachitol of 1L-chiro-inositol 2,3,5-trisphosphate, an inhibitor of the enzymes of 1D-myo-inositol 1,4,5-trisphosphate metabolism
暂无分享,去创建一个
[1] A. P. Briggs. A MODIFICATION OF THE BELL-DOISY PHOSPHATE METHOD , 1922 .
[2] S. Hanessian,et al. Regioselective manipulation of hydroxyl groups via organotin derivatives , 1985 .
[3] M. Berridge,et al. Inositol trisphosphate and diacylglycerol: two interacting second messengers. , 1987, Annual review of biochemistry.
[4] A. Trzeciak,et al. A Simple and Effective Chemical Phosphorylation Procedure for Biomolecules , 1987 .
[5] S H Snyder,et al. Solubilization, purification, and characterization of an inositol trisphosphate receptor. , 1988, The Journal of biological chemistry.
[6] J. Huff,et al. Metabolism of synthetic inositol trisphosphate analogs. , 1988, The Journal of biological chemistry.
[7] Teiichi Furuichi,et al. Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400 , 1989, Nature.
[8] B. Potter,et al. myo‐Inositol 1,4,5‐trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5‐phosphatase , 1989, FEBS letters.
[9] R. Huganir,et al. Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles , 1989, Nature.
[10] B. Potter,et al. Molecular recognition of inositol polyphosphates by intracellular receptors and metabolic enzymes. , 1989, Trends in pharmacological sciences.
[11] H. Carless,et al. Total synthesis of chiro-inositol 2,3,5-trisphosphate: A myo-inositol 1,4,5-trisphosphate analogue from benzene via photo-oxidation , 1990 .
[12] B. Potter,et al. Recent advances in the chemistry and biochemistry of inositol phosphates of biological interest. , 1990, Natural product reports.
[13] M. Hirata,et al. Stereospecific recognition of inositol 1,4,5-trisphosphate analogs by the phosphatase, kinase, and binding proteins. , 1990, The Journal of biological chemistry.
[14] R. Wojcikiewicz,et al. Ca2+‐mobilising properties of synthetic fluoro‐analogues of myo‐inositol 1,4,5‐trisphosphate and their interaction with myo‐inositol 1,4,5‐trisphosphate 3‐kinase and 5‐phosphatase , 1990, FEBS letters.
[15] T. Südhof,et al. Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. , 1990, The Journal of biological chemistry.
[16] C. Ballou,et al. Synthesis and Ca(2+)-release activity of D- and L-myo-inositol 2,4,5-trisphosphate and D- and L-chiro-inositol 1,3,4-trisphosphate. , 1991, Carbohydrate research.
[17] R. Wojcikiewicz,et al. Interaction of synthetic D‐6‐deoxy‐myo‐inositol 1,4,5‐trisphosphate with the Ca2+‐releasing D‐myo‐inositol 1,4,5‐trisphosphate receptor, and the metabolic enzymes 5‐phosphatase and 3‐kinase , 1991, FEBS letters.
[18] R. Wojcikiewicz,et al. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase. , 1991, Molecular pharmacology.
[19] S. Penadés,et al. The allylation of dibutylstannylene derivatives of myo-inositol , 1992 .
[20] B. Potter,et al. 3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition. , 1992, European journal of pharmacology.